• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during pregnancy and nursing is challenging for women with the condition. There aren't many studies on how exposure to ADHD for a long time could affect a pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders such as hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the foetus. The doctors don't have the information to make unambiguous recommendations however they can provide information on risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry found that women who took natural adhd medication medications in early pregnancy did not face an higher risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a massive population-based study of case control to examine the prevalence of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to reduce any bias.

The study conducted by the researchers had some limitations. In particular, they were not able to differentiate the effects of the medication from those of the underlying disorder. This limitation makes it difficult to know whether the limited associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. Researchers also did not examine long-term outcomes for the offspring.

The study did show that babies whose mothers had taken ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the higher risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean birth or having a child with an low Apgar score (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, if they are able, assist them in developing strategies for improving their coping skills that may minimize the negative impact of her condition on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research suggests on the subject and their own judgments for each patient.

In particular, the issue of possible risks to the baby can be tricky. The research on this subject is based on observations rather than controlled studies and the results are in conflict. Most studies focus on live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these issues by analyzing data on live and deceased births.

The conclusion: While some studies have shown a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies demonstrate a neutral or slightly negative impact. Therefore an accurate risk-benefit analysis is required in every instance.

For women suffering from ADHD who suffer from ADHD, the decision to discontinue medication is difficult if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A loss of medication may also affect the ability to drive safely and perform work-related tasks, which are essential aspects of everyday life for those with ADHD.

She recommends that women who are unsure about whether or not to stop taking medication because of their pregnancy, consider the possibility of educating friends, family members, and coworkers on the condition, its impact on daily functioning, and the advantages of staying on the current treatment plan. It will also help a woman feel confident about her decision. Certain medications can pass through the placenta. If the patient decides to not take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the medication could be transferred to the infant.

Birth Defects Risk

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as does the concern about the potential adverse effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. Using two massive data sets researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medication use increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medications was linked to a slightly higher rate of certain heart defects like ventriculo-septal defects (VSD).

The authors of the study could not discover any connection between early use of medication and congenital anomalies like facial deformities, or club feet. The results are in agreement with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication prior to pregnancy. The risk grew in the latter half of pregnancy, when a lot of women decide to stop taking their medication.

Women who were taking adhd medication pregnancy medication during the first trimester were more likely require a caesarean delivery or have a low Apgar after delivery, and have a baby that needed help breathing at birth. The researchers of the study could not eliminate selection bias because they limited the study to women without other medical conditions that might have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of physicians who treat pregnant women. They advise that while discussing the risks and benefits is crucial however, the decision to stop or maintain treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also caution that, while stopping the medication is an option, it isn't an option that is recommended due to the high prevalence of depression and other mental health problems among women who are pregnant or who are recently post-partum. Research has also shown that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to a nursing infant is low because the majority of stimulant medications is absorbed through breast milk at low levels. The rate of medication exposure will differ based on dosage and frequency of administration as well as the time of the day. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't well understood.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. It is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the risks to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have a background of ADHD or if they plan to take medication in the perinatal phase.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are choosing to do this. They have found after consulting with their doctor, that the benefits of continuing their current medication outweigh risk.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and the underlying disorder. They should also be educated about treatment options and reinforce the coping mechanisms. This should involve an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.